In addition, we found that CCL21 affects the TME landscape of HCC characterized by inhibition of N2 neutrophil polarization and promotion of CD8+ T-cell infiltration, which makes HCC more sensitive to anti-programmed death-1 (PD-1) therapy in the preclinical model. The gene discussed is CD8A; the disease is hepatocellular carcinoma.